Literature DB >> 25365921

Pituitary gland: mortality in acromegaly reduced with multimodal therapy.

Nienke R Biermasz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25365921     DOI： 10.1038/nrendo.2014.193

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly.

Authors:  I M Holdaway; M J Bolland; G D Gamble
Journal:  Eur J Endocrinol       Date:  2008-06-04       Impact factor: 6.664

2.  Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study.

Authors:  Fausto Bogazzi; Annamaria Colao; Giuseppe Rossi; Martina Lombardi; Claudio Urbani; Chiara Sardella; Aldo Iannelli; Ilaria Scattina; Luca Manetti; Simone Del Sarto; Rosario Pivonello; Ludovica Francesca Stella Grasso; Isabella Lupi; Renata Simona Auriemma; Gaetano Lombardi; Enio Martino
Journal:  Eur J Endocrinol       Date:  2013-08-28       Impact factor: 6.664

3.  Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality.

Authors:  Anne Marij G Burgers; Nienke R Biermasz; Jan W Schoones; Alberto M Pereira; Andrew G Renehan; Marcel Zwahlen; Matthias Egger; Olaf M Dekkers
Journal:  J Clin Endocrinol Metab       Date:  2011-07-27       Impact factor: 5.958

Review 4.  Mortality in patients with pituitary disease.

Authors:  Mark Sherlock; John Ayuk; Jeremy W Tomlinson; Andrew A Toogood; Aurora Aragon-Alonso; Michael C Sheppard; Andrew S Bates; Paul M Stewart
Journal:  Endocr Rev       Date:  2010-01-19       Impact factor: 19.871

Review 5.  Guidelines for acromegaly management: an update.

Authors:  S Melmed; A Colao; A Barkan; M Molitch; A B Grossman; D Kleinberg; D Clemmons; P Chanson; E Laws; J Schlechte; M L Vance; K Ho; A Giustina
Journal:  J Clin Endocrinol Metab       Date:  2009-02-10       Impact factor: 5.958

6.  Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic.

Authors:  Moises Mercado; Baldomero Gonzalez; Guadalupe Vargas; Claudia Ramirez; Ana Laura Espinosa de los Monteros; Ernesto Sosa; Paola Jervis; Paola Roldan; Victoria Mendoza; Blas López-Félix; Gerardo Guinto
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

7.  Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements.

Authors:  Nienke R Biermasz; Friedo W Dekker; Alberto M Pereira; Sjoerd W van Thiel; Pieter J Schutte; Hans van Dulken; Johannes A Romijn; Ferdinand Roelfsema
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

8.  Mortality in acromegaly: a metaanalysis.

Authors:  O M Dekkers; N R Biermasz; A M Pereira; J A Romijn; J P Vandenbroucke
Journal:  J Clin Endocrinol Metab       Date:  2007-10-30       Impact factor: 5.958

9.  Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

Authors:  B Swearingen; F G Barker; L Katznelson; B M Biller; S Grinspoon; A Klibanski; N Moayeri; P M Black; N T Zervas
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

10.  A paradigm shift in the monitoring of patients with acromegaly: last available growth hormone may overestimate risk.

Authors:  Mark Sherlock; Raoul C Reulen; Aurora Aragon-Alonso; John Ayuk; Richard N Clayton; Michael C Sheppard; Michael M Hawkins; Andrew S Bates; Paul M Stewart
Journal:  J Clin Endocrinol Metab       Date:  2013-11-15       Impact factor: 5.958
  10 in total
  3 in total

1.  Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.

Authors:  Liliya Rostomyan; Adrian F Daly; Patrick Petrossians; Emil Nachev; Anurag R Lila; Anne-Lise Lecoq; Beatriz Lecumberri; Giampaolo Trivellin; Roberto Salvatori; Andreas G Moraitis; Ian Holdaway; Dianne J Kranenburg-van Klaveren; Maria Chiara Zatelli; Nuria Palacios; Cecile Nozieres; Margaret Zacharin; Tapani Ebeling; Marja Ojaniemi; Liudmila Rozhinskaya; Elisa Verrua; Marie-Lise Jaffrain-Rea; Silvia Filipponi; Daria Gusakova; Vyacheslav Pronin; Jerome Bertherat; Zhanna Belaya; Irena Ilovayskaya; Mona Sahnoun-Fathallah; Caroline Sievers; Gunter K Stalla; Emilie Castermans; Jean-Hubert Caberg; Ekaterina Sorkina; Renata Simona Auriemma; Sachin Mittal; Maria Kareva; Philippe A Lysy; Philippe Emy; Ernesto De Menis; Catherine S Choong; Giovanna Mantovani; Vincent Bours; Wouter De Herder; Thierry Brue; Anne Barlier; Sebastian J C M M Neggers; Sabina Zacharieva; Philippe Chanson; Nalini Samir Shah; Constantine A Stratakis; Luciana A Naves; Albert Beckers
Journal:  Endocr Relat Cancer       Date:  2015-07-17       Impact factor: 5.678

Review 2.  New therapeutic agents for acromegaly.

Authors:  Shlomo Melmed
Journal:  Nat Rev Endocrinol       Date:  2015-11-27       Impact factor: 43.330

Review 3.  Pasireotide: a novel treatment for patients with acromegaly.

Authors:  Daniel Cuevas-Ramos; Maria Fleseriu
Journal:  Drug Des Devel Ther       Date:  2016-01-11       Impact factor: 4.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.